Scientific article
OA Policy
English

Safety and efficacy of tenecteplase versus alteplase in acute coronary syndrome: a systematic review and meta-analysis of randomized trials

Published in

Archives of Medical Science, vol. 12, no. 6, p. 1181-1187

Publication date

2016

Abstract

Alteplase and tenecteplase are two widely used thrombolytic agents and are both approved for the treatment of acute myocardial infarction. These two molecules have increased fibrin specificity compared with older thrombolytics but distinct pharmacokinetic properties and may differ in terms of risks and benefits. We decided to review the available evidence comparing the safety and efficacy of these two molecules in acute coronary syndrome (ACS) or pulmonary embolism (PE).

Citation (ISO format)

GUILLERMIN, Alexandre et al. Safety and efficacy of tenecteplase versus alteplase in acute coronary syndrome: a systematic review and meta-analysis of randomized trials. In: Archives of Medical Science, 2016, vol. 12, n° 6, p. 1181–1187. doi: 10.5114/aoms.2016.58929

Main files (1)

Article (Published version)

Identifiers

Journal ISSN

1734-1922
719views
421downloads

Technical informations

Creation

04/11/2017 09:19:00

First validation

04/11/2017 09:19:00

Update

15/03/2023 02:17:10

Status update

15/03/2023 02:17:09

Last indexation

31/10/2024 08:26:42
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated